Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

618.88 -1.71 (-0.28%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Earnings Scheduled For April 24, 2023 ↗

April 24, 2023

Companies Reporting Before The Bell • Dynex Cap (NYSE:DX) is estimated to report quarterly earnings at $0.17 per share on revenue of $6.99 million.

Via Benzinga

Earnings Outlook For Medpace Hldgs ↗

April 21, 2023

Via Benzinga

Thermo Fisher Stock Sets Up In Healthy Base; Earnings Due ↗

April 11, 2023

Thermo Fisher stock is among the top 3 in the Medical-Research Equipment/Services industry group. It got a key rating upgrade Tuesday.

Via Investor's Business Daily

Medpace Hldgs's Earnings: A Preview ↗

February 10, 2023

Via Benzinga

Why Medpace Stock Soared Today ↗

October 25, 2022

The clinical trial specialist is winning new business at an impressive clip.

Via The Motley Fool

Medpace Holdings, Inc. to Report First Quarter 2023 Financial Results on April 24, 2023

March 28, 2023

From Medpace Holdings, Inc.

Via Business Wire

Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade ↗

March 11, 2023

A basket balanced evenly across these three businesses could jump-start your journey to becoming a millionaire.

Via The Motley Fool

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results

February 13, 2023

From Medpace Holdings, Inc.

Via Business Wire

Better Healthcare Buy for 2023: Medpace Holdings or Doximity? ↗

January 14, 2023

The healthcare stocks expect similar revenue growth in 2023.

Via The Motley Fool

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023

January 04, 2023

From Medpace Holdings, Inc.

Via Business Wire

Earnings Scheduled For February 13, 2023 ↗

February 13, 2023

Companies Reporting Before The Bell • EuroDry (NASDAQ:EDRY) is expected to report quarterly earnings at $2.68 per share on revenue of $21.20 million.

Via Benzinga

Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally ↗

December 17, 2022

UnitedHealth is among medical stocks holding key support.

Via Investor's Business Daily

Veracyte Stock Showing Market Leadership; Earns 93 RS Rating ↗

December 01, 2022

Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

These 4 Superb Growth Stocks Are Beating the Nasdaq Bear Market: Is It Too Late to Buy? ↗

November 08, 2022

There's good reason to expect these businesses to continue their histories of outperformance, regardless of market conditions.

Via The Motley Fool

Coke's Fizz, Weber's Proposed Deal, and Stock Market Superstitions ↗

October 29, 2022

There's a lot for investors to think about.

Via The Motley Fool

Why Medpace Holdings Jumped 41.5% This Week ↗

October 28, 2022

The clinical contract research organization is seeing an increase in new business.

Via The Motley Fool

Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review ↗

October 28, 2022

The Dow and S&P 500 moved above a key level while the Nasdaq rose.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022 ↗

October 27, 2022

Upgrades

Via Benzinga

Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings ↗

October 25, 2022

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 25, 2022

Gainers

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

Stocks Pop As "Fear Gauge" Cools Off ↗

October 25, 2022

Stocks have shrugged off premarket losses and are confidently higher ahead of Big Tech earnings.

Via Talk Markets

Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗

October 25, 2022

Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.

Via Investor's Business Daily

Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session ↗

October 25, 2022

Gainers

Via Benzinga

S&P 500 Rises Over 1%; General Motors Earnings Top Views ↗

October 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday.

Via Benzinga

Peering Into Medpace Hldgs's Recent Short Interest ↗

October 25, 2022

Medpace Hldgs's (NASDAQ:MEDP) short percent of float has risen 11.68% since its last report. The company recently reported that it has 2.20 million shares sold short, which is 10.52% of all regular...

Via Benzinga

Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday ↗

October 25, 2022

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today ↗

October 25, 2022

Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.08% on an annualized basis producing an average annual return of 43.37%. Currently, Medpace Hldgs has a market...

Via Benzinga

US Stocks Open Higher; Dow Rises Over 100 Points ↗

October 25, 2022

U.S. stocks traded higher this morning, with the Dow Jones surging more than 100 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 25, 2022

Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

All News about Medpace Holdings, Inc. - Common Stock